NUDCD1 抗体 (AA 431-530) (Biotin)
-
- 抗原 See all NUDCD1 products
- NUDCD1 (NudC Domain Containing 1 (NUDCD1))
-
抗原表位
- AA 431-530
-
适用
- 小鼠
-
宿主
- 兔
-
克隆类型
- 多克隆
-
标记
- This NUDCD1 antibody is conjugated to Biotin
-
应用范围
- Western Blotting (WB), ELISA, Immunohistochemistry (Paraffin-embedded Sections) (IHC (p)), Immunohistochemistry (Frozen Sections) (IHC (fro))
- 交叉反应
- 小鼠
- 预测反应
- Human,Rat,Dog,Cow,Sheep,Horse,Rabbit,Zebrafish
- 纯化方法
- Purified by Protein A.
- 免疫原
- KLH conjugated synthetic peptide derived from human NUDCD1
- 亚型
- IgG
-
-
- 应用备注
-
WB 1:300-5000
IHC-P 1:200-400
IHC-F 1:100-500 - 限制
- 仅限研究用
-
- 状态
- Liquid
- 浓度
- 1 μg/μL
- 缓冲液
- Aqueous buffered solution containing 0.01M TBS ( pH 7.4) with 1 % BSA, 0.03 % Proclin300 and 50 % Glycerol.
- 储存液
- ProClin
- 注意事项
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.
- 储存条件
- -20 °C
- 储存方法
- Store at -20°C for 12 months.
- 有效期
- 12 months
-
- 抗原
- NUDCD1 (NudC Domain Containing 1 (NUDCD1))
- 别名
- NUDCD1 (NUDCD1 产品)
- 别名
- Cml66 antibody, NUDCD1 antibody, CML66 antibody, OVA66 antibody, 4921532K09Rik antibody, AA407246 antibody, AW260430 antibody, AW556235 antibody, CML66-L antibody, RGD1310624 antibody, im:6901299 antibody, im:6912119 antibody, wu:fc11c02 antibody, zgc:110705 antibody, cml66 antibody, NudC domain containing 1 antibody, NudC domain-containing protein 1 antibody, NudC domain containing 1 S homeolog antibody, NUDCD1 antibody, nudcd1 antibody, CpipJ_CPIJ019282 antibody, nudc1 antibody, LOC777229 antibody, Nudcd1 antibody, nudcd1.S antibody
- 背景
-
Synonyms: 4921532K09Rik, AA407246, AW260430, AW556235, Chronic myelogenous leukemia tumor antigen 66, CML66, CML66 L, FLJ14991, NudC domain containing 1, NudC domain-containing protein 1, NUDC1_HUMAN, nudcd1, OVA66, RGD1310624, Tumor antigen CML66.
Background: The NUDCD1 gene encodes the 583 amino acid CML66 protein which demonstrates expression in a variety of solid tumor cell lines and leukemias. Expression of CML66 in normal tissues is restricted to testis and heart. The CML66 antibody is found in sera of 18-38 % of patients with lung cancer, melanoma or prostate cancer. These findings indicate that CML66 may be immunogenic in a wide variety of malignancies and may be a target for antigen-specific immunotherapy. A short isoform of CML66, designated CML66-S, is a product of alternative splicing. CML66-S has the same C-terminus as full-lenghth CML66 (also designated CML66-L), but has a unique N-terminus. CML66-S shows predominant expression in testis, and is also expressed in very low levels in tumor cells, while CML66 is expressed in tumor cells and testis.
- 基因ID
- 84955
- UniProt
- Q96RS6
-